Emma Luong-Van

Chief Technology Officer | , Netherlands

Professional Overview

Emma Luong-Van is a seasoned technology leader with expertise in material science and medical device development. As the Chief Technology Officer at LipoCoat, she is responsible for driving the company's innovative research and development efforts, overseeing the implementation of cutting-edge technologies, and ensuring the successful commercialization of novel biomedical solutions.

Experience Summary

Current Role

As the Chief Technology Officer at LipoCoat, Emma leads a team of talented researchers and engineers in the development of innovative biomaterial coatings for medical devices. She is instrumental in guiding the company's technology roadmap, fostering cross-functional collaboration, and ensuring the timely delivery of transformative products that address critical unmet needs in the healthcare industry.

Career Progression

Prior to her current role, Emma served as a Senior Researcher at LipoCoat, where she made significant contributions to the company's research and development initiatives. She has also held esteemed positions as a Senior Research Fellow at the National University of Singapore, a Business Development Manager at Dornier MedTech, and a Biodesign Fellow at the Singapore-Stanford Biodesign program. Earlier in her career, Emma was a Research Scientist at the ASTAR Institute of Materials Research and Engineering and a PhD Researcher at the ASTAR Institute of Molecular and Cell Biology.

Academic Background

Emma holds a PhD in Bioengineering from the A*STAR Institute of Molecular and Cell Biology, where her research focused on the development of novel biomaterials for tissue engineering applications. Her academic achievements include numerous publications in peer-reviewed journals and presentations at international conferences.

Areas of Expertise

• Material science and biomaterial engineering

• Medical device design and development

• Translational research and commercialization

• Cross-functional team leadership and collaboration

• Strategic technology roadmapping and implementation

Professional Impact

Under Emma's leadership, LipoCoat has achieved notable successes, including the successful development and regulatory approval of several groundbreaking biomedical coatings that have significantly improved patient outcomes and enhanced the performance of medical devices. Her innovative approaches and unwavering commitment to advancing the field of biomaterials have positioned her as a respected thought leader in the industry.

Conclusion

With her exceptional technical expertise, strong track record of innovation, and proven leadership abilities, Emma Luong-Van is poised to continue driving transformative change in the medical technology sector. As the Chief Technology Officer at LipoCoat, she is committed to leveraging the power of cutting-edge materials science to develop solutions that improve the quality of life for patients worldwide.